DRUG

Bright Minds BiosciencesD

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-21

View Chart

Peers tracked

U.S. public peers

Grade Position

Below peers

vs peer average

DRUG vs peer average

26/100

DRUG vs. peer average (D vs. B)

Grade spread

A 3 · B 3 · C 1 · D 2 · F 1

Graded peers loaded

Coverage

10 graded

100% of tracked

Peer overview

ACAD is the first available peer comparator.

CNS-focused developer with similar regulatory and commercial execution risks; useful comparator for readout-driven re-ratings.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerACADACADIA

DRUG

Bright Minds Biosciences

ACAD

ACADIA

Grade

Momentum

Value

Sentiment

Setup Bias

Net —

Market Cap

Posture

Defensive

Constructive

Open Side-by-Side Comparison Compare all

Grade position vs ACAD

DRUG / ACAD

Grade Position

Below peers

DRUG vs. peer average (D vs. B)

26/100

Momentum

ACAD

Value

ACAD

Sentiment

DRUG

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs DRUG

ACAD

100/100

-3

IONQ

20/100

DSGN

Design Therapeutics Inc Common

80/100

-2

MNPR

Monopar Therapeutics Inc Common

80/100

-2

CLYM

Climb Bio Inc Common

40/100

Even

ACAD is the first peer returned for this comparison set.